Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Stereotactic Radiosurgery Alone for One to Two Brain Metastases from Cancer of Unknown Primary.

Dziggel L, Bajrovic A, Schild SE, Rades D.

Anticancer Res. 2018 Jan;38(1):565-567.

PMID:
29277825
2.
3.

Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.

Feldkamp T, Luedemann M, Spehlmann ME, Freitag-Wolf S, Gaensbacher J, Schulte K, Bajrovic A, Hinzmann D, Hippe HJ, Kunzendorf U, Frey N, Luedde M.

Clin Res Cardiol. 2018 Feb;107(2):148-157. doi: 10.1007/s00392-017-1166-2. Epub 2017 Sep 22.

PMID:
28939956
4.

Heart failure is associated with depletion of core intestinal microbiota.

Luedde M, Winkler T, Heinsen FA, Rühlemann MC, Spehlmann ME, Bajrovic A, Lieb W, Franke A, Ott SJ, Frey N.

ESC Heart Fail. 2017 Aug;4(3):282-290. doi: 10.1002/ehf2.12155. Epub 2017 Apr 21.

5.
6.

A New Scoring Tool to Assess Overall Survival in Patients With Intracerebral Metastases From Gynecological Cancers.

Rades D, Janssen S, Bajrovic A, Veninga T, Fischer D, Schild SE.

Int J Gynecol Cancer. 2017 Mar;27(3):597-602. doi: 10.1097/IGC.0000000000000899.

PMID:
28187091
7.

Clinical Factors Asssociated with Treatment Outcomes following Whole-brain Irradiation in Patients with Prostate Cancer.

Dziggel L, Schild SE, Veninga T, Bajrovic A, Rades D.

In Vivo. 2017 Jan 2;31(1):35-38. Review.

8.

A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases.

Rades D, Janssen S, Dziggel L, Blanck O, Bajrovic A, Veninga T, Schild SE.

BMC Cancer. 2017 Jan 6;17(1):30. doi: 10.1186/s12885-016-2989-3.

9.

Comparison of 20×2 Gy and 12×3 Gy for Whole-brain Irradiation of Multiple Brain Metastases from Malignant Melanoma.

Rades D, Sehmisch L, Bajrovic A, Janssen S, Schild SE.

In Vivo. 2016 11-12;30(6):917-919.

PMID:
27815480
10.
11.

Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancers.

Rades D, Seidl D, Janssen S, Strojan P, Karner K, Bajrovic A, Hakim SG, Wollenberg B, Schild SE.

Eur Arch Otorhinolaryngol. 2017 Feb;274(2):1021-1027. doi: 10.1007/s00405-016-4326-5. Epub 2016 Sep 29.

PMID:
27687678
12.

Overall Survival After Whole-Brain Radiation Therapy for Intracerebral Metastases from Testicular Cancer.

Rades D, Dziggel L, Veninga T, Bajrovic A, Schild SE.

Anticancer Res. 2016 Sep;36(9):4817-9.

PMID:
27630334
13.

Local Therapies Can Improve Intracerebral Control in Patients with Cerebral Metastasis from Gynecological Cancers.

Dziggel L, Janssen S, Bajrovic A, Veninga T, Trang NT, Khoa MT, Schild SE, Rades D.

Anticancer Res. 2016 Sep;36(9):4777-80.

PMID:
27630327
14.

Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeks.

Rades D, Strojan P, Seidl D, Janssen S, Bajrovic A, Kazic N, Hakim SG, Wollenberg B, Schild SE.

J Craniomaxillofac Surg. 2016 Sep;44(9):1436-40. doi: 10.1016/j.jcms.2016.06.033. Epub 2016 Jul 7.

PMID:
27499514
15.

Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?

Rades D, Seidl D, Janssen S, Bajrovic A, Hakim SG, Wollenberg B, Karner K, Strojan P, Schild SE.

Oral Oncol. 2016 Aug;59:67-72. doi: 10.1016/j.oraloncology.2016.06.004.

PMID:
27424184
16.

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m(2) for definitive radiochemotherapy of locally advanced head-and-neck cancers.

Rades D, Seidl D, Janssen S, Bajrovic A, Karner K, Strojan P, Schild SE.

BMC Cancer. 2016 Jul 8;16:437. doi: 10.1186/s12885-016-2478-8.

17.

A Total Radiation Dose of 70 Gy Is Required After Macroscopically Incomplete Resection of Squamous Cell Carcinoma of the Head and Neck.

Rades D, Janssen S, Bajrovic A, Strojan P, Schild SE.

Anticancer Res. 2016 Jun;36(6):2989-92.

PMID:
27272815
18.

Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer?

Rades D, Seidl D, Janssen S, Bajrovic A, Hakim SG, Wollenberg B, Schild SE.

Oral Oncol. 2016 Jun;57:40-5. doi: 10.1016/j.oraloncology.2016.04.003. Epub 2016 Apr 25.

PMID:
27208843
19.

Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer.

Seidl D, Janssen S, Strojan P, Bajrovic A, Schild SE, Rades D.

Anticancer Res. 2016 May;36(5):2523-6.

PMID:
27127167
20.

Forecasting Survival Probabilities After Radiotherapy of Metastatic Epidural Spinal Cord Compression from Colorectal Cancer in the Elderly.

Rades D, Bartscht T, Janssen S, Bajrovic A, Segedin B, Schild SE.

Anticancer Res. 2016 Apr;36(4):1829-33.

PMID:
27069166

Supplemental Content

Loading ...
Support Center